dry, irritated, itchy skin L85.3
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Dry, itchy, irritated skin (Body and extremities) Male and female subjects Pruritus intensity minim. NRS 3 No systemic therapy in the last 2 weeks or no systemic antihistamine medication and no topical therapy for the past week Informed consent Agreement to stop using the currently applying body-care products and to replace them by the study product Agreement to follow carefully the to the study related obligations and the advices of the investigators .
Exclusion criteria
Exclusion criteria: Dry, itchy, irritated skin only in the face For female subjects: Pregnancy or lactation Active psychosomatic or psychiatric diseases Clear unstable or uncontrolled medical condition, diagnosed by the Investigator (e.g. cardiovascular, immunologic, haematological, hepatic, neurological, endocrine, gastrointestinal, urogenital, soft tissue concerning incidents or diseasesI Existence of an active systemic or dermatologic infection Known active malign basic disease Drug- or alcohol abuse, medicines abuse identified by the investigator Topical use of Tacrolimus, Pimecrolimus, Polidocanol, Menthol, Cannabinoidagonists or Capsaicin in the last week preceding the study Oral intake of Steroids, Cyclosporin A, or other immunsupressiva, Naltrexone, UV-therapy, in the two last weeks preceding the start of the study Oral intake of antihistaminic drugs in the last week preceding the onset of the study Acute exacerbation of a dermatosis or of cutaneous infections Known allergy or sensitivity to one or more of the components of the study preparation Participation to an other clinical study in the month preceding the inclusion to this study Employee of the CRO or of the Sponsor or near relatives (partner, kids, parents, sisters and brothers, or kids of them) of an employee
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cosmetic caring properties of Waid Cream. Assessment via questionnaire and by measurement of skin hydration (corneometry) and of transepidermal water loss before starting and after two weeks of twice daily application. | — |
Secondary
| Measure | Time frame |
|---|---|
| Soothing potential (Itch, burning, stinging), and application of the new validated 5PLQ questionnaire in dry skin. Assessments before and after two weeks of twice daily application. | — |
Countries
Germany
Contacts
Medicos Service GmbH